STAAR Surgical (STAA) Tops Q1 EPS by 8c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
STAAR Surgical Reports First Quarter 2020 Results
May 6, 2020 4:01 PM EDTLAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2020.
First Quarter 2020 Overview
Net Sales of $35.2 Million Up 8% from the Prior Year Quarter ICL Sales of $29.3 Million Up 6% and Units Up 9% from the Prior Year Quarter Gross Margin at 70.4% vs. 74.2% in the Prior Year Quarter Net Loss Approximately Breakeven per Share vs.... More